- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-43-0035102

Inverse Pharmaceuticals Private Limited
About Inverse Pharmaceuticals Private Limited
Data last updated:
Inverse Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2021PTC142858. Its GSTIN is 09AAGCI0487E1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors Shruti Sachan and Sujeet Singh Sachan.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at D – 196 D Block Barra – 8, Kanpur, Uttar Pradesh, India – 208027.
As per the financials filed for FY 2023, the company reported a revenue of ₹47.09 Lakh, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹11,551 (net margin 0.2%) and EBITDA of ₹1.69 Lakh (EBITDA margin 3.6%).
Inverse Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0035102).
Company details
Recognitions & Rankings of Inverse Pharmaceuticals
Contact details
Inverse Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressD – 196 D Block Barra – 8, Kanpur, Uttar Pradesh, India – 208027
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Inverse Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inverse Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inverse Pharmaceuticals Private Limited, buy the company report.
Financials of Inverse Pharmaceuticals Private Limited
FY 2023 filings availableInverse Pharmaceuticals Private Limited reported revenue of ₹47.09 Lakh (up 42% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 42% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.69 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹11,551 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.6% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Inverse Pharmaceuticals Private Limited, buy the company report.
Board of directors of Inverse Pharmaceuticals Private Limited
Inverse Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shruti Sachan | Director | 04 Mar 2021 | 5 Years 8 Months | Current |
| Sujeet Singh Sachan | Additional Director | 13 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Inverse Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KHK Pharmaceuticals Private Limited | ₹47.22 Lakh (FY 2023) | 183.0% | New Delhi, Delhi, India | |||
| Corden Pharma Private Limited | ₹47.14 Lakh (FY 2023) | -15.0% | Mumbai, Maharashtra, India | |||
| Inverse Pharmaceuticals Private Limitedthis company | ₹47.09 Lakh (FY 2023) | ₹11,551 | 0.2% | 42.0% | Kanpur, Uttar Pradesh, India | |
| RDW Pharmaceuticals Private Limited | ₹47.05 Lakh (FY 2024) | 15.0% | Mumbai, Maharashtra, India | |||
| Alkyd Pharmaceuticals Private Limited | ₹47.01 Lakh (FY 2023) | -32.0% | Dhanbad, Jharkhand, India |
To see the full peer comparison of Inverse Pharmaceuticals Private Limited, buy the company report.
Auditor
Inverse Pharmaceuticals Private Limited is audited by AMIT BALVANT & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT BALVANT & CO. | FY 2022 | 021246C |
Shareholding
The shareholding of Inverse Pharmaceuticals Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Inverse Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inverse Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inverse Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Inverse Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Inverse Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCI0487E1ZJ | Uttar Pradesh | Active | 20 Mar 2021 |
To see the full GST registrations and return filing status of Inverse Pharmaceuticals Private Limited, buy the company report.
Recent activity
Inverse Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Sujeet Singh Sachan was appointed as Additional Director on 13 May 2022.
Frequently asked questions
Inverse Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 March 2021 (5+ years old) and is registered under CIN U24230UP2021PTC142858.
Inverse Pharmaceuticals has 2 current directors:
- Shruti Sachan - Director
- Sujeet Singh Sachan - Additional Director
The latest financial statements of Inverse Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Inverse Pharmaceuticals is 09AAGCI0487E1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Inverse Pharmaceuticals is U24230UP2021PTC142858. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inverse Pharmaceuticals was incorporated on 04 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Inverse Pharmaceuticals by revenue are KHK Pharmaceuticals Private Limited, Corden Pharma Private Limited, RDW Pharmaceuticals Private Limited, Alkyd Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sujeet Singh Sachan was appointed as Additional Director on 13 May 2022. Devendra Kumar Singh ceased to be Director on 10 May 2022. Shruti Sachan was appointed as Director on 04 Mar 2021.
Yes, Inverse Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0035102).
The registered office of Inverse Pharmaceuticals is at D – 196 D Block Barra – 8, Kanpur, Uttar Pradesh, India – 208027.
Inverse Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

